Nexalin (Nasdaq: NXL) appoints Carmi Masha to market Gen-2 SYNC device across Israel
- Posted on November 13, 2025
- By Google News
- 2 Views
Nexalin (Nasdaq: NXL) appoints Carmi Masha to market Gen-2 SYNC device across Israel
Following Israeli Ministry of Health approval authorizing SYNC sales for insomnia, depression and anxiety, Carmi Masha will lead sales, importation and distribution.
